S. Kashiwagi

发表

Safety and efficacy of the neuraminidase inhibitor zanamivir in treating influenza virus infection in adults: results from Japan. GG167 Group.

S. Kudoh, K. Shimokata, K. Shirato, 1999, Antiviral therapy.

[Efficacy and safety of the selective oral neuraminidase inhibitor oseltamivir for prophylaxis against influenza--placebo-controlled double-blind multicenter phase III trial].

S. Kudoh, A. Watanabe, I. Yoshimura, 2000, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

[Clinical efficacy and safety of the selective oral neuraminidase inhibitor oseltamivir in treating acute influenza--placebo-controlled double-blind multicenter phase III trial].

S. Kudoh, A. Watanabe, I. Yoshimura, 2000, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of the influenza virus circulating in the Japanese 2013-2014 season.

H. Ikematsu, Naoki Kawai, N. Iwaki, 2015, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.